$RGNX 0.31 Weak
- Date
- Aug 24, 2026
- Mentions
- 1
- Unique authors
- 1
- Sector
- other
- Stance
- neutral
- On card
- no
Sentiment history
bullish
neutral
mixed
bearish
line = signal
dashed = price
No sentiment history available for $RGNX yet.
Sentiment
bullish 1
neutral 1
Notable posts
-
bullish 20 eng
$RGNX says the FDA agreed no additional patients or studies are needed for its NAVSUNLI BLA resubmission for MPS II / Hunter syndrome. The FDA said existing clinical data is sufficient for accelerated approval review and no untreated control arm is required. Regenxbio expects a Type A meeting in July and plans to resubmit the BLA in Q3 2026.
view on X → -
neutral 26 eng
Tenet Pre-Market Movers August.24.26 $SDOT $NSSC $BMEA $VNDA $SGML $IE $STLD $NUE $OCS $EXK $CLF $PDD $RGNX $AAOI $COHR $SNDK $DTIL $XPEV $STX $VRXA $USAR $MU $BABA @ripster47 | @tenet_research | @TenetCharts https://t.co/BkwNaYFZfb
view on X →
Signal history
| Date | Score | Signal | Mentions | Rank |
|---|---|---|---|---|
| 2026-06-22 | 0.50 | Developing | 1 | — |
| 2026-08-24 | 0.31 | Weak | 1 | — |